Patents by Inventor Vikki Spaulding

Vikki Spaulding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200190187
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Application
    Filed: December 27, 2019
    Publication date: June 18, 2020
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Patent number: 10544217
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Grant
    Filed: May 11, 2016
    Date of Patent: January 28, 2020
    Assignee: PD-1 Acquisition Group, LLC
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Patent number: 10239942
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Grant
    Filed: December 19, 2015
    Date of Patent: March 26, 2019
    Assignee: PD-1 Acquisition Group, LLC
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Publication number: 20160319019
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Application
    Filed: May 11, 2016
    Publication date: November 3, 2016
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon
  • Publication number: 20160251436
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Application
    Filed: December 19, 2015
    Publication date: September 1, 2016
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon
  • Patent number: 8048984
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Grant
    Filed: December 1, 2008
    Date of Patent: November 1, 2011
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20110262390
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Application
    Filed: May 23, 2011
    Publication date: October 27, 2011
    Applicant: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Patent number: 7951372
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Grant
    Filed: August 31, 2007
    Date of Patent: May 31, 2011
    Assignee: Wyeth LLC
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20100260767
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Application
    Filed: January 15, 2010
    Publication date: October 14, 2010
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20090232809
    Abstract: The present invention provides novel isolated CRF2-13 polynucleotides and polypeptides encoded by the CRF2-13 polynucleotides. Also provided are the antibodies that immunospecifically bind to a CRF2-13 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the CRF2-13 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the CRF2-13 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: September 18, 2008
    Publication date: September 17, 2009
    Inventors: Wei Liu, Lynette Fouser, Vikki Spaulding
  • Publication number: 20090227772
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Application
    Filed: December 1, 2008
    Publication date: September 10, 2009
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Patent number: 7585646
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: September 8, 2009
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Patent number: 7459533
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: December 2, 2008
    Assignee: Genetics Institute, LLC.
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20080139452
    Abstract: Novel polynucleotides and the proteins encoded thereby are disclosed.
    Type: Application
    Filed: December 13, 2007
    Publication date: June 12, 2008
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Kenneth Jacobs, John M. McCoy, Edward R. LaVallie, Lisa A. Collins-Racie, David Merberg, Michael J. Agostino, Robert Steininger, Vikki Spaulding, Gordon G. Wong, Hilary F. Clark, Kim Fechtel, Cheryl Evans, Maurice Treacy
  • Patent number: 7344861
    Abstract: Novel polynucleotides and the proteins encoded thereby are disclosed.
    Type: Grant
    Filed: April 3, 2006
    Date of Patent: March 18, 2008
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Kenneth Jacobs, John M. McCoy, Edward R. LaVallie, Lisa A. Collins-Racie, David Merberg, Michael J. Agostino, Robert J. Steininger, II, Vikki Spaulding, Gordon G. Wong, Hilary F. Clark, Kim Fechtel, Cheryl Evans, Maurice Treacy
  • Patent number: 7307161
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: December 11, 2007
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Patent number: 7279559
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: October 9, 2007
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20060269957
    Abstract: Novel polynucleotides and the proteins encoded thereby are disclosed.
    Type: Application
    Filed: July 12, 2006
    Publication date: November 30, 2006
    Applicant: Ono Pharmaceutical Co. Ltd.
    Inventors: Kenneth Jacobs, John McCoy, Edward LaVallie, Lisa Collins-Racie, Cheryl Evans, David Merberg, Maurice Treacy, Michael Bowman, Vikki Spaulding, McKeough Carlin-Duckett, Kerry Kelleher
  • Publication number: 20060177904
    Abstract: Novel polynucleotides and the proteins encoded thereby are disclosed.
    Type: Application
    Filed: April 3, 2006
    Publication date: August 10, 2006
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Kenneth Jacobs, John McCoy, Edward LaVallie, Lisa Collins-Racie, David Merberg, Michael Agostino, Robert Steininger, Vikki Spaulding, Gordon Wong, Hilary Clark, Kim Fechtel, Cheryl Evans, Maurice Treacy
  • Publication number: 20060063227
    Abstract: Novel polynucleotides and the proteins encoded thereby are disclosed.
    Type: Application
    Filed: December 14, 2004
    Publication date: March 23, 2006
    Inventors: Kenneth Jacobs, John McCoy, Edward LaVallie, Lisa Collins-Racie, Cheryl Evans, David Merberg, Maurice Treacy, Michael Bowman, Vikki Spaulding, Michael Agostino